Literature DB >> 8991861

Intestinal permeability in the ileal pouch.

M N Merrett1, N Soper, N Mortensen, D P Jewell.   

Abstract

BACKGROUND: Villous atrophy, mucin changes ('colonic metaplasia'), and chronic inflammation occur to varying degrees in all patients with ileal pouchanal anastomosis whereas acute inflammation (pouchitis) affects a subgroup of patients with prior ulcerative colitis. AIM: To measure epithelial barrier function looking for possible functional adaptation in ileal 'pouch' mucosa. PATIENTS: Patients with an ileal pouch prior to ileostomy closure (n = 12), functioning pouch (n = 14), pouchitis (n = 8), and ulcerative colitis (n = 12) were assessed.
METHODS: 51Cr-EDTA was administered into the 'pouch' or rectum and urinary recovery over 24 hours was taken as an indication of permeability (barrier function). Histological analysis of 'pouch' biopsy specimens was undertaken.
RESULTS: Mucosal permeability is decreased from median 9.4% (range 5.4% to 39.1%) to 1.4% (range 0.38% to 2.2%) after ileostomy closure (p < 0.002) with levels being negatively correlated with two histological parameters of colonic metaplasia-mucin changes (p = 0.03) and villous atrophy (p = 0.05). Pouchitis was associated with increased permeability 5.9% (1.9% to 19.5%) compared with healthy 'pouch' 1.4% (0.35 to 2.2%) (p < 0.006).
CONCLUSION: Despite the presence of chronic inflammation in the mature 'pouch' functional adaptation with reduced permeability occurs in conjunction with colonic metaplasia.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8991861      PMCID: PMC1383303          DOI: 10.1136/gut.39.2.226

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  42 in total

1.  Restorative proctocolectomy with ileal reservoir.

Authors:  R R Dozois; S M Goldberg; D A Rothenberger; J Utsunomiya; R J Nicholls; Z Cohen; L A Hultén; R L Moskowitz; N S Williams
Journal:  Int J Colorectal Dis       Date:  1986-01       Impact factor: 2.571

2.  Lactulose, 51Cr-labelled ethylenediaminetetra-acetate, L-rhamnose and polyethyleneglycol 400 [corrected] as probe markers for assessment in vivo of human intestinal permeability.

Authors:  D G Maxton; I Bjarnason; A P Reynolds; S D Catt; T J Peters; I S Menzies
Journal:  Clin Sci (Lond)       Date:  1986-07       Impact factor: 6.124

Review 3.  Progress with the pouch--restorative proctocolectomy for ulcerative colitis.

Authors:  N Mortensen
Journal:  Gut       Date:  1988-05       Impact factor: 23.059

4.  Cigarette smoking and inflammatory bowel disease.

Authors:  M V Tobin; R F Logan; M J Langman; R B McConnell; I T Gilmore
Journal:  Gastroenterology       Date:  1987-08       Impact factor: 22.682

5.  Pouch ileitis--recurrence of the inflammatory bowel disease in the ileal reservoir.

Authors:  H Knobler; M Ligumsky; E Okon; A Ayalon; R Nesher; D Rachmilewitz
Journal:  Am J Gastroenterol       Date:  1986-03       Impact factor: 10.864

6.  Smoking may prevent pouchitis in patients with restorative proctocolectomy for ulcerative colitis.

Authors:  M N Merrett; N Mortensen; M Kettlewell; D O Jewell
Journal:  Gut       Date:  1996-03       Impact factor: 23.059

7.  Radionuclide tests for the assessment of intestinal permeability.

Authors:  R H Behrens; K F Szaz; C Northrop; M Elia; G Neale
Journal:  Eur J Clin Invest       Date:  1987-04       Impact factor: 4.686

8.  Enteric bacteriology, absorption, morphology and emptying after ileal pouch-anal anastomosis.

Authors:  P R O'Connell; D R Rankin; L H Weiland; K A Kelly
Journal:  Br J Surg       Date:  1986-11       Impact factor: 6.939

9.  Absorption of 51chromium-labeled ethylenediaminetetraacetate in inflammatory bowel disease.

Authors:  I Bjarnason; C O'Morain; A J Levi; T J Peters
Journal:  Gastroenterology       Date:  1983-08       Impact factor: 22.682

10.  Epithelial permeability and the transepithelial migration of human neutrophils.

Authors:  L C Milks; M J Brontoli; E B Cramer
Journal:  J Cell Biol       Date:  1983-05       Impact factor: 10.539

View more
  9 in total

1.  The jejunal pouch as a rectal substitute after proctocolectomy.

Authors:  F V Teixeira; M Hinojosa-Kurtzberg; M Pera; R B Hanson; J W Williams; K A Kelly
Journal:  J Gastrointest Surg       Date:  2000 Mar-Apr       Impact factor: 3.452

Review 2.  Acute and chronic pouchitis--pathogenesis, diagnosis and treatment.

Authors:  Bo Shen
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-04-17       Impact factor: 46.802

3.  Serum biochemical evaluation of patients with functional pouches ten to 20 years after restorative proctocolectomy.

Authors:  Amosy Ephreim M'Koma
Journal:  Int J Colorectal Dis       Date:  2006-01-26       Impact factor: 2.571

4.  Inflamed pouch mucosa possesses altered tight junctions indicating recurrence of inflammatory bowel disease.

Authors:  Salah Amasheh; Sonja Dullat; Michael Fromm; Jörg D Schulzke; Heinz J Buhr; Anton J Kroesen
Journal:  Int J Colorectal Dis       Date:  2009-06-02       Impact factor: 2.571

Review 5.  Pouchitis: a spectrum of diseases.

Authors:  Bo Shen; Bret A Lashner
Journal:  Curr Gastroenterol Rep       Date:  2005-10

6.  Impairment of epithelial transport but not of barrier function in idiopathic pouchitis after ulcerative colitis.

Authors:  A J Kroesen; M Stockmann; C Ransco; J D Schulzke; M Fromm; H J Buhr
Journal:  Gut       Date:  2002-06       Impact factor: 23.059

7.  Mucin gene expression in the ileoanal reservoir is altered and may be relevant to the risk of inflammation and dysplasia.

Authors:  P A Sylvester; M Walsh; N Myerscough; B F Warren; A P Corfield; M G Thomas; P Durdey
Journal:  Gut       Date:  2002-09       Impact factor: 23.059

Review 8.  Pouchitis.

Authors:  En-Da Yu; Zhuo Shao; Bo Shen
Journal:  World J Gastroenterol       Date:  2007-11-14       Impact factor: 5.742

Review 9.  Tight junctions in inflammatory bowel diseases and inflammatory bowel disease associated colorectal cancer.

Authors:  Jonathan Landy; Emma Ronde; Nick English; Sue K Clark; Ailsa L Hart; Stella C Knight; Paul J Ciclitira; Hafid Omar Al-Hassi
Journal:  World J Gastroenterol       Date:  2016-03-21       Impact factor: 5.742

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.